查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466587

临床前 CRO 市场：按服务、应用和最终用户划分 - 2024-2030 年全球预测

Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年临床前CRO市场规模为62.5亿美元，预计2024年将达68.5亿美元，2030年将达到119.5亿美元，复合年增长率为9.68%。

临床前 CRO 是支援中心，提供必要的研发活动 (R&D) 专业知识，透过动物试验将候选药物带入临床阶段。临床前测试服务包括多项研究，这些研究对于评估药物在动物模型中的功效和安全性以及提交临床实验(IND) 申请非常重要。在临床前试验中，CRO受申办者（例如生物製药公司）聘请，代表申办者执行一系列业务，同时承担各种技术和行政职责。处于临床前阶段的药物数量迅速增加，以及药物开发的研发 (R&D) 预算不断增加，正在推动临床前 CRO 服务的使用。然而，临床前CRO服务涉及高成本和耗时的流程，阻碍了市场成长。高通量筛检和In Silico建模等技术进步预计将实现更有效率、更具成本效益的临床前研究，为市场成长创造机会。

主要市场统计
基准年[2023] 62.5亿美元
预测年份 [2024] 68.5亿美元
预测年份 [2030] 119.5亿美元
复合年增长率（%） 9.68%

毒理学测试服务的使用率迅速增加，重点关注服务安全和监管合规方面

生物分析和 DMPK 研究对于了解潜在疗法的吸收、分布、代谢和排泄 (ADME) 特性至关重要。该部分提供了有关生物系统中药物行为的重要信息，对于确定剂量和评估安全性至关重要。这些研究优先在药物开发的早期阶段进行，此时需要详细了解药物的药物动力学特征。製药和生物技术公司通常依赖具有生物分析方法和最尖端科技专业知识的外部 CRO。毒理学测试服务对于评估候选药物的安全性、确保其进一步开发和人类消费的安全性至关重要。该领域涉及各种测试来评估化合物对生物体的潜在不利影响。这些测试在进行临床试验之前非常重要，主要解决药物必须通过才能获得核准的监管要求。对于所有需要证明其产品无毒的製药和生物技术公司来说，这一点至关重要。

最终用户：生物製药公司扩大临床前 CRO 的使用

生物製药公司是临床前 CRO 的主要客户，利用他们的服务来开发和测试生物製药。这些公司寻求与 CRO 合作，利用他们在药理学、毒理学和分子生物学方面的专业知识。向生物製药公司提供的服务通常包括功效和安全性评估、吸收、分布、代谢和排泄 (ADME) 测试以及监管支持。与临床前 CRO 合作使生物製药公司能够加快药物开发流程、有效管理成本并有效满足复杂的监管要求。政府机构和学术机构与临床前 CRO 合作，进行公共卫生目的的研究和发展。这些合作关係支持新药发现、疫苗开发和创新治疗方法等计划。临床前 CRO 为这些机构提供了获得其内部所没有的专业资源和专业知识的机会。此外，CRO 还帮助进行高品质、合规的研究，从而实现突破性的医学进步。政府/学术机构和 CRO 之间的合作对于弥合基础研究和临床应用之间的差距至关重要。医疗设备製造商依靠临床前 CRO 的服务来检验其产品的安全性和有效性，然后再进行临床试验。这些公司受益于 CRO 的技术和监管专业知识来进行全面的生物医学测试、动态评估和风险评估。为医疗设备公司量身定制的服务通常包括临床前研究设计、原型测试以及对遵守国际标准和法规的支援。透过与 CRO 合作，医疗设备公司可以确保其产品符合最高品质和安全标准，确保顺利过渡到临床阶段。

区域洞察

人口老化导致的非传染性疾病以及污染和虫害等环境条件变化引起的传染性疾病空前增加，催生了医疗保健领域对有效药物开发的需求，从而导致对临床前 CRO 服务的需求日益迫切。 、中东和非洲地区不断增加。亚太地区政府为促进医疗设备和药物开发领域的研发 (R&D) 活动而进行的投资预计将为临床前 CRO 市场的参与者提供成长机会。 2021年8月，澳洲政府投资7,900万美元用于医疗创新和研究计划。欧盟新兴经济体建立了政府支持体系，透过优先考虑新技术和药物开发的研究和创新来支持技术进步。各国政府推出了多项严格的法规和标准，以确保开发的药品和设备安全、可靠和高品质。 2022年1月，决定在欧盟启动修订临床试验流程的临床试验法规（Regulation (EU) No 536/2014）。政府引入了临床试验资讯系统（CTIS）来协调监督和评估流程。因此，政府对医疗设备和药物开发临床试验的持续支持预计将推动欧洲、中东和非洲临床前 CRO 市场的成长。

FPNV定位矩阵

FPNV定位矩阵对于评估临床前CRO市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对临床前 CRO 市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 临床前CRO市场的市场规模与预测是多少？

2.临床前CRO市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3. 临床前CRO市场的技术趋势和法规结构是什么？

4.临床前CRO市场主要厂商的市场占有率如何？

5. 进入临床前CRO市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药和生物製药公司增加研发活动以开发新药和治疗方法
      • 製药公司将药物开发业务外包给 CRO 的趋势增加
      • 个人化医疗的发展日益受到关注
    • 抑制因素
      • 与临床前 CRO 服务相关的高成本和耗时的限制
    • 机会
      • 技术进步使临床前研究更有效率、更具成本效益
      • 单株抗体、疫苗和细胞疗法等生技药品临床前研究的巨大潜力
    • 任务
      • 国际监管机构制定的严格法规和准则
  • 市场区隔分析
    • 服务：毒理学测试服务的使用正在迅速增加，重点关注安全和监管合方面。
    • 最终用户：改变生物製药公司使用临床前 CRO 的方式
  • 市场趋势分析
    • 美洲的老牌製药和生物製药公司越来越多，先进的临床前 CRO 平台也不断引进。
    • 政府加强支持力度，扩大亚太地区新药和医疗设备开发的研发活动
    • 政府对药物开发活动的潜在资助将扩大欧洲、中东和非洲地区的临床前 CRO 业务。
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章临床前CRO市场：依服务分类

  • 生物分析和 DMPK 研究
  • 毒性试验

第七章 临床前 CRO 市场：依应用分类

  • 循环系统疾病
  • 皮肤科
  • 胃
  • 泌尿系统和女性健康
  • 血液学
  • 免疫疾病
  • 感染疾病
  • 代谢紊乱
  • 神经病学
  • 肿瘤学
  • 眼科
  • 呼吸系统疾病

第八章临床前 CRO 市场：依最终使用者分类

  • 生物製药公司
  • 政府和学术机构
  • 医疗设备公司

第九章美洲临床前CRO市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区临床前CRO市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲临床前CRO市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • CRO公司TriApex完成君联资本主导的C轮资金筹措
    • PsychoGenics 推出 eCube，一个用于新药发现的人工智慧平台
    • 普鲁士宣布大幅扩展临床前研究和开发，以加速药物安全决策
    • AmplifyBio 扩展了细胞疗法的表征并缩小了临床前开发的差距
    • Clinchoice 透过收购 CRO 继续扩张
    • QPS 在台湾开设新的临床前研究设施
    • CRO Avanir 收购明讯
    • Apax 收购 Porsolt 多数股权，支持公司的成长策略并成为临床前服务的全球领导者
    • Cryoport 宣布与 Syneos Health 建立策略合作伙伴关係，以推进细胞和基因治疗
    • Crown Biosciences 与 ERS ​​Genomics 宣布签署全球 CRISPR/Cas9 基因组编辑专利授权协议
    • Domain Therapeutics 与 Exprycyte 签署免疫肿瘤学领域合作协议
    • 赛扬扩大早期临床药理学部门
    • ClinChoice 在 E 轮融资中筹集 1.5 亿美元
    • Hella Biolab 宣布与 Charles River 签署全球独家授权合约
    • IonsGate 临床前服务和 InSilicoTrials 合作

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEFA51A

[195 Pages Report] The Preclinical CRO Market size was estimated at USD 6.25 billion in 2023 and expected to reach USD 6.85 billion in 2024, at a CAGR 9.68% to reach USD 11.95 billion by 2030.

A preclinical CRO is a support center providing expertise in research and development activities (R&D) essential for navigating a drug candidate through animal testing and forwarding it into the clinical phase. Preclinical research services encompass several studies critical to assessing drug efficacy & safety in animal models and complete Investigational New Drug (IND) filing studies. In a preclinical trial, CROs are hired by sponsors such as biopharma companies to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor's behalf. A surge in the number of drugs in the preclinical phase and an increased research & development (R&D) budget for drug development are driving the usage of preclinical CRO services. The high cost and time-consuming process of preclinical CROS services hamper the market growth. Advances in technology, which include high-throughput screening and in silico modeling, enable more efficient and cost-effective preclinical research and are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 6.25 billion
Estimated Year [2024] USD 6.85 billion
Forecast Year [2030] USD 11.95 billion
CAGR (%) 9.68%

Services: Burgeoning usage of Toxicology testing services focusing on the safety and regulatory compliance aspects

Bioanalysis and DMPK studies are crucial for understanding potential therapeutic agents' absorption, distribution, metabolism, and excretion (ADME) properties. This segment provides vital information on the drug's behavior in a biological system, which is paramount for dosage determination and safety assessment. These studies are preferred in the early stages of drug development when detailed insight into the drug's pharmacokinetic profile is required. Pharmaceutical companies and biotechnology firms often rely on external CROs with specialized expertise in bioanalytical methodologies and state-of-the-art technologies. Toxicology testing services are vital for evaluating the safety profile of drug candidates, ensuring they are safe for further development and human consumption. This segment encompasses a range of studies to assess the potential adverse effects of compounds on living organisms. These tests are critical before advancing to clinical trials, catering mainly to regulatory requirements that drugs must pass for approval. They are indispensable for all pharmaceutical and biotechnological companies needing to demonstrate the non-toxic nature of their products.

End-User: Evolving usage of preclinical CRO by biopharmaceutical companies

Biopharmaceutical companies are primary clients of preclinical CROs, leveraging their services for the development and testing of biologic drugs. These companies seek CRO partnerships to access specialized expertise in pharmacology, toxicology, and molecular biology. Services offered to biopharmaceutical companies often include drug efficacy and safety assessments, absorption, distribution, metabolism, excretion (ADME) studies, and regulatory support. Collaborating with preclinical CROs enables biopharmaceutical companies to accelerate their drug development process, manage costs effectively, and navigate complex regulatory requirements efficiently. Government and academic institutes often engage with preclinical CROs for research and development initiatives fundamental to public health objectives. These partnerships support projects, including new drug discoveries, vaccine development, and innovative medical treatments. Preclinical CROs provide these institutions with access to specialized resources and expertise that may not be available in-house. Additionally, CROs assist in conducting high-quality, regulatory-compliant research studies that can lead to groundbreaking medical advancements. Collaborations between government / academic institutes and CROs are pivotal in bridging the gap between basic research and clinical application. Medical device companies utilize preclinical CRO services to validate the security and efficacy of their products before proceeding to clinical trials. These companies benefit from CROs' technical and regulatory expertise to conduct comprehensive biomedical testing, biomechanical evaluation, and risk assessment. Services tailored to medical device companies often encompass preclinical study design, prototype testing, and support in complying with international standards and regulations. By partnering with CROs, medical device companies can assure their products meet the highest quality and safety standards, facilitating smoother transitions into clinical phases.

Regional Insights

The unprecedented rise in non-communicable diseases among the geriatric population and communicable diseases caused by changing environmental conditions, such as pollution, and insect infestation, create a demand for effective drug development in the healthcare sector, subsequently increasing the need for preclinical CRO services across the Americas, Asia-Pacific, and EMEA. The investments made by the governments of Asia-Pacific to push research and development (R&D) activities of medical devices and drug development are estimated to provide growth opportunities for the preclinical CRO market players. In August 2021, the Australian government invested USD 79 million in medical innovation and research projects. The developed economies in the European Union have established a supportive government framework to boost technological advancements by prioritizing research and innovation of new technologies and drug development. The government introduces several stringent regulations and standards to ensure that the medicines and devices developed are safe, reliable, and of high quality. In January 2022, the Clinical Trials Regulation (Regulation (EU) No 536/2014) was set to launch in the EU to modify the clinical trial processes. The government introduced a Clinical Trials Information System (CTIS) to harmonize the supervision and assessment processes. Thus, the ongoing government support for clinical trials for medical devices and drug development is expected to fuel the growth of the preclinical CRO market in EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Preclinical CRO Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Preclinical CRO Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Preclinical CRO Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AmplifyBio, Atuka Inc., BenchSci, Bioserve Biotechnologies (India) PVT Ltd. by REPROCELL Inc., Biotrofix, Inc., Celerion, Charles River Laboratories International, Inc., Crown Bioscience, Inc., CTI Clinical Trial and Consulting, Inc., Diag2Tec SAS, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Gubra, Hera Biolabs, ICON PLC, Immusmol SAS, ImQuest BioSciences, Inotiv, Inc., Intertek Group PLC, Invivotek by Genesis Biotechnology Group, LLC, IQVIA Inc., Jubilant Biosys Ltd. byJubilant Pharmova Limited Company, Laboratory Corporation of America Holding, MCI Group Holding SA, MD Biosciences, Medpace Holdings, Inc., Novartis AG, Parexel International Corporation., PharmaCircle LLC, Phenos GmbH, PPD by Thermo Fisher Scientific Inc., PsychoGenics Inc., QPS Holdings, LLC, Sanofi S.A., SCiAN Services Inc., SGS SA, Shanghai Medicilon Inc., Syneos Health, Inc., Transpharmation, Veristat, LLC, Vimta Labs Limited, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical CRO Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Bioanalysis & DMPK Studies
    • Toxicology Testing
  • Application
    • Cardiovascular Disease
    • Dermatology
    • Gastrointestinal
    • Genitourinary & Women's Health
    • Hematology
    • Immunological Disorders
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
    • Ophthalmology
    • Respiratory Disorders
  • End-User
    • Biopharmaceutical Companies
    • Government & Academic Institutes
    • Medical Device Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Preclinical CRO Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Preclinical CRO Market?

3. What are the technology trends and regulatory frameworks in the Preclinical CRO Market?

4. What is the market share of the leading vendors in the Preclinical CRO Market?

5. Which modes and strategic moves are suitable for entering the Preclinical CRO Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing R&D activities by pharmaceutical and biopharmaceutical companies to develop new drugs & therapies
      • 5.1.1.2. Rising trend of outsourcing drug development activities to CROs by pharmaceutical companies
      • 5.1.1.3. Growing focus on the development of personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and time-consuming constraints associated with preclinical CRO services
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing advances in technologies to enable more efficient and cost-effective preclinical research
      • 5.1.3.2. High potential for preclinical research for biologics, including monoclonal antibodies, vaccines, and cell therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and guidelines set by international regulatory authorities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Burgeoning usage of Toxicology testing services focusing on the safety and regulatory compliance aspects
    • 5.2.2. End-User: Evolving usage of preclinical CRO by biopharmaceutical companies
  • 5.3. Market Trend Analysis
    • 5.3.1. Presence of well-established pharmaceutical & biopharmaceutical companies and the rising introduction of advanced preclinical CRO platforms in the Americas
    • 5.3.2. Rising government support for expanding research & development activities into developing new drugs and medical devices in the Asia-Pacific region
    • 5.3.3. Potential government funding in drug development activities expands the preclinical CRO business in the EMEA region.
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis
  • 5.8. Client Customization

6. Preclinical CRO Market, by Services

  • 6.1. Introduction
  • 6.2. Bioanalysis & DMPK Studies
  • 6.3. Toxicology Testing

7. Preclinical CRO Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Dermatology
  • 7.4. Gastrointestinal
  • 7.5. Genitourinary & Women's Health
  • 7.6. Hematology
  • 7.7. Immunological Disorders
  • 7.8. Infectious Diseases
  • 7.9. Metabolic Disorders
  • 7.10. Neurology
  • 7.11. Oncology
  • 7.12. Ophthalmology
  • 7.13. Respiratory Disorders

8. Preclinical CRO Market, by End-User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Government & Academic Institutes
  • 8.4. Medical Device Companies

9. Americas Preclinical CRO Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Preclinical CRO Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Preclinical CRO Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. CRO Company TriApex Completes Series C Financing Round Led by Legend Capital
    • 12.3.2. PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
    • 12.3.3. Proscia Announces Major Expansion in Preclinical R&D to Drive Faster Drug Safety Decisions
    • 12.3.4. AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development
    • 12.3.5. Clinchoice Continues Expansion with CRO Acquisition
    • 12.3.6. QPS opens an additional preclinical research facility in Taiwan
    • 12.3.7. CRO Avania Acquires MAXIS
    • 12.3.8. Apax Acquires a Majority Stake in Porsolt to Support its Growth Strategy and Become a Global Leader in Preclinical Services
    • 12.3.9. Cryoport Announces Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
    • 12.3.10. Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
    • 12.3.11. Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology
    • 12.3.12. Celerion Expands Early Phase Clinical Pharmacology Units
    • 12.3.13. ClinChoice Raises USD 150 Million in Series E Round
    • 12.3.14. Hera BioLabs Announces Exclusive Global License With Charles River
    • 12.3.15. IonsGate Preclinical Services and InSilicoTrials Form Partnership

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL CRO MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL CRO MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PRECLINICAL CRO MARKET DYNAMICS
  • FIGURE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECLINICAL CRO MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECLINICAL CRO MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 102. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 114. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 115. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 120. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 121. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 126. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 127. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 138. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 139. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 150. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 151. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 156. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 157. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 162. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 163. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 175. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 176. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 177. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 182. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 183. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 188. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 189. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 194. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 195. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 200. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 201. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 206. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 207. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 212. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 213. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 224. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 225. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 230. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 231. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 236. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 237. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 242. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 243. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 248. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 249. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 254. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 255. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 261. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 266. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 267. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 272. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 273. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 278. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 279. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 284. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 285. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 296. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 297. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 302. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2023